Pax6 dosage requirements in iris and ciliary body differentiation

Noa Davis, Chen Yoffe, Shaul Raviv, Ran Antes, Joachim Berger, Silvia Holzmann, Anastassia Stoykova, Paul A Overbeek, Ernst R Tamm, Ruth Ashery-Padan

Research output: Contribution to journalArticleResearchpeer-review

41 Citations (Scopus)

Abstract

Pax6 is a highly conserved transcription factor that controls the morphogenesis of various organs. Changes in Pax6 dosage have been shown to affect the formation of multiple tissues. PAX6 haploinsufficiency leads to aniridia, a pan-ocular disease primarily characterized by iris hypoplasia. Herein, we employ a modular system that includes null and overexpressed conditional alleles of Pax6. The use of the Tyrp2-Cre line, active in iris and ciliary body (CB) primordium, enabled us to investigate the effect of varying dosages of Pax6 on the development of these ocular sub-organs. Our findings show that a lack of Pax6 in these regions leads to dysgenesis of the iris and CB, while heterozygosity impedes growth of the iris and maturation of the iris sphincter. Overexpression of the canonical, but not the alternative splice variant of Pax6 results in severe structural aberrations of the CB and hyperplasia of the iris sphincter. A splice variant-specific rescue experiment revealed that both splice variants are able to correct iris hypoplasia, while only the canonical form rescues the sphincter. Overall, these findings demonstrate the dosage-sensitive roles of Pax6 in the formation of both the CB and the iris.
Original languageEnglish
Pages (from-to)132 - 142
Number of pages11
JournalDevelopmental Biology
Volume333
Issue number1
DOIs
Publication statusPublished - 2009

Cite this